Progression of fibrosis in patients with chronic viral hepatitis is associated with <scp>IL</scp> ‐17 ⁺ neutrophils

Abstract

Our data indicate that neutrophils represent an important source of IL-17 in the human liver, especially in late fibrosis stages. Inhibition of this specific harmful subset of neutrophils may offer therapeutic opportunities in fibrotic liver.